Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
NCT ID: NCT02203227
Last Updated: 2014-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2014-08-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
NCT02100202
Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults
NCT07196514
Effect of the Combination of Plant Extracts (BSL_EP025) in Cardiovascular Health
NCT04029727
Curcumin & Astaxanthin for Lowering Triglyceride Readings and Inflammation
NCT07063056
Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function
NCT04520126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Capsule containing 250 mg of placebo, two times a day
Placebo
BioTurmin
Capsule containing 250 mg of BioTurmin (Curcuma longa rhizomes extract), two times a day
BioTurmin (Curcuma longa rhizomes extract)
BioTurmin-WD
Capsule containing 250 mg of BioTurmin-WD (water dispersible curcuminoids), two times a day
BioTurmin-WD (Water dispersible curcuminoids)
MaQxan
Capsule containing 10 mg of MaQxan (Tagetes erecta flower extract), two times a day
MaQxan
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
BioTurmin (Curcuma longa rhizomes extract)
BioTurmin-WD (Water dispersible curcuminoids)
MaQxan
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic cigarette/ beedi smoker (2-3 packets/day since last 3 years or more) with mild to moderate hyperlipidemia (LDL ranging 160-189 mg/dL, TC \>200 mg/dL and/or HDL-C \<40 mg/dL)
* Being mentally competent and able to understand all study requirements and sign the informed consent form.
Exclusion Criteria
* Women
* Patients with severe liver, renal, cardiac or brain diseases.
* Unable to complete follow up.
* Subjects on any medication like diuretics.
* Allergic to any medication.
* With a history of alcohol and/or drug abuse.
20 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Olive Lifesciences Pvt Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Venkateshwarlu K, MD (Ayur)
Role: PRINCIPAL_INVESTIGATOR
Sreenivasa Clinic Diabetic Research Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sreenivasa Clinic Diabetic Research Center
Bangalore, Karnataka, India
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Dietary supplements
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OLS-SH/06-14 VER 01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.